Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Left Ventricular Remodeling After Acute Myocardial Infarction by Inhibiting Monocyte-Mediated Inflammation.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International Heart Journal

• Publication date

  2017-07-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1536/ihj.16-457PMID 28701679
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening

  2016cited by this paper
• Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE −/− Mice

  2016cited by this paper
• A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model

  2015cited by this paper
• Intermediate monocytes lead to enhanced myocardial remodelling in STEMI patients with diabetes.

  2015cited by this paper
• Delivery of imatinib-incorporated nanoparticles into lungs suppresses the development of monocrotaline-induced pulmonary arterial hypertension.

  2015cited by this paper
• Monocytes in Myocardial Infarction

  2015cited by this paper
• Monocytes and macrophages: developmental pathways and tissue homeostasis

  2014cited by this paper
• Nanoparticle-mediated drug delivery system for cardiovascular disease.

  2014cited by this paper
• Remote ischemic preconditioning for myocardial protection: update on mechanisms and clinical relevance

  2014cited by this paper
• Nanoparticle-Mediated Delivery of Pitavastatin Inhibits Atherosclerotic Plaque Destabilization/Rupture in Mice by Regulating the Recruitment of Inflammatory Monocytes

  2014cited by this paper
• Pitavastatin-incorporated nanoparticle-eluting stents attenuate in-stent stenosis without delayed endothelial healing effects in a porcine coronary artery model.

  2013cited by this paper
• Regulation of the inflammatory response in cardiac repair.

  2012cited by this paper
• Extramedullary Hematopoiesis Generates Ly-6Chigh Monocytes That Infiltrate Atherosclerotic Lesions

  2012cited by this paper
• Nanoparticle-Mediated Delivery of Pitavastatin Into Lungs Ameliorates the Development and Induces Regression of Monocrotaline-Induced Pulmonary Artery Hypertension

  2011cited by this paper
• Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: report from the MIYAGI-AMI Registry Study.

  2010cited by this paper
• Monocytes: protagonists of infarct inflammation and repair after myocardial infarction.

  2010cited by this paper
• Angiotensin-Converting Enzyme Inhibition Prevents the Release of Monocytes From Their Splenic Reservoir in Mice With Myocardial Infarction

  2010cited by this paper
• Intracoronary Administration of Cardiac Progenitor Cells Alleviates Left Ventricular Dysfunction in Rats With a 30-Day-Old Infarction

  2010cited by this paper
• Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis.

  2010cited by this paper
• Trends in Acute Myocardial Infarction Incidence and Mortality Over 30 Years in Japan

  2010cited by this paper
• Nanoparticle-Mediated Delivery of Nuclear Factor &kgr;B Decoy Into Lungs Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension

  2009cited by this paper
• Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries.

  2009cited by this paper
• Dispensable But Not Irrelevant

  2009cited by this paper
• Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites

  2009cited by this paper
• Essential Role of Angiotensin II Type 1a Receptors in the Host Vascular Wall, but Not the Bone Marrow, in the Pathogenesis of Angiotensin II–Induced Atherosclerosis

  2008cited by this paper
• The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions

  2007cited by this paper
• Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice.

  2007cited by this paper
• Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages.

  2006cited by this paper
• A large-scale prospective cohort study on the current status of therapeutic modalities for acute myocardial infarction in Japan: rationale and initial results of the HIJAMI Registry.

  2005cited by this paper
• HMG-CoA Reductase Inhibition Reduces Monocyte CC Chemokine Receptor 2 Expression and Monocyte Chemoattractant Protein-1–Mediated Monocyte Recruitment In Vivo

  2005cited by this paper
• Critical Role of Monocyte Chemoattractant Protein-1 Receptor CCR2 on Monocytes in Hypertension-Induced Vascular Inflammation and Remodeling

  2004cited by this paper
• Fluvastatin, a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction

  2002cited by this paper
• Angiotensin II Induces Migration and Pyk2/Paxillin Phosphorylation of Human Monocytes

  2001cited by this paper
• The Journal of Experimental Medicine

  2000cited by this paper
• Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method.

  1999cited by this paper
• Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications

  1990cited by this paper

• Drp1-mediated mitochondrial fission protects macrophages from mtDNA/ZBP1-mediated inflammation and inhibits post-infarct cardiac remodeling.

  2026cites this paper
• The spleen in ischaemic heart disease

  2025cites this paper
• Nanoparticles For Rescue: Innovative Therapeutic Strategy For Cardiac Repair After Myocardial Infarction

  2025cites this paper
• HDL and LDL-bioinspired nanocarriers in acellular targeted delivery of Icariin for cardiac repair post myocardial infarction.

  2025cites this paper
• The future of cardiac repair: a review on cell-free nanotherapies for regenerative myocardial infarction

  2025cites this paper
• The Influence of Metabolic Risk Factors on the Inflammatory Response Triggered by Myocardial Infarction: Bridging Pathophysiology to Treatment

  2024cites this paper
• Drp1-mediated mitochondrial fission protects macrophages from mtDNA/ZBP1-mediated sterile inflammation and inhibits post-infarct cardiac remodeling

  2024cites this paper
• A bibliography of smart nanomaterials biological application in myocardial infarction research

  2024cites this paper
• Tissue Engineering and Targeted Drug Delivery in Cardiovascular Disease: The Role of Polymer Nanocarrier for Statin Therapy

  2023cites this paper
• An Overview of Nanomaterial Applications in Pharmacology

  2023cites this paper
• Intravascularly Deliverable Biomaterial Platforms for Tissue Repair and Regeneration Post‐Myocardial Infarction

  2023cites this paper
• Control of the post-infarct immune microenvironment through biotherapeutic and biomaterial-based approaches

  2023cites this paper
• Subthreshold splenic nerve stimulation prevents myocardial Ischemia-Reperfusion injury via neuroimmunomodulation of proinflammatory factor levels.

  2023cites this paper
• Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target

  2022cites this paper
• Engineering of Immune Microenvironment for Enhanced Tissue Remodeling

  2022influential citation
• Caffeic Acid-Grafted PLGA as a Novel Material for the Design of Fluvastatin-Eluting Nanoparticles for the Prevention of Neointimal Hyperplasia

  2022cites this paper
• The role of cyclophilins in viral infec and the immune response.

  2022cites this paper
• Nanoparticles in the diagnosis and treatment of vascular aging and related diseases

  2022cites this paper
• PITAVASTATIN COMBINED WITH PLGA DRUG DELIVERY SYSTEM AS A POTENTIAL ADJUVANT THERAPY FOR CORONARY ARTERY DISEASE

  2022cites this paper
• Nanoparticles Targeting the Molecular Pathways of Heart Remodeling and Regeneration

  2022cites this paper
• Role of Nanotechnology and Their Perspectives in the Treatment of Kidney Diseases

  2022cites this paper
• Combined Therapeutics for Atherosclerosis Treatment Using Polymeric Nanovectors

  2022cites this paper
• Nanoparticle‐Mediated Simultaneous Targeting of Mitochondrial Injury and Inflammation Attenuates Myocardial Ischemia‐Reperfusion Injury

  2021cites this paper
• Polymers and Nanoparticles for Statin Delivery: Current Use and Future Perspectives in Cardiovascular Disease

  2021cites this paper
• Necroptosis and RhoA/ROCK pathways: molecular targets of Nesfatin-1 in cardioprotection against myocardial ischemia/reperfusion injury in a rat model

  2021cites this paper
• Pitavastatin-Incorporated Nanoparticles for Chronic Limb Threatening Ischemia: A Phase I/IIa Clinical Trial

  2021cites this paper
• Animal models used in the research of nanoparticles for cardiovascular diseases

  2021cites this paper
• Pravastatin attenuates atherosclerosis after myocardial infarction by inhibiting inflammatory Ly6Chigh monocytosis in apolipoprotein E knockout mice

  2020cites this paper
• Nanoparticle delivery of cardioprotective therapies.

  2020cites this paper
• Nanoparticle-Mediated Drug Delivery for Treatment of Ischemic Heart Disease

  2020cites this paper
• Simultaneous targeting of mitochondria and monocytes enhances neuroprotection against ischemia–reperfusion injury

  2020cites this paper
• The Dynamics of Circulating Monocyte Subsets and Intra-Plaque Proliferating Macrophages during the Development of Atherosclerosis in ApoE-/- Mice.

  2019cites this paper
• Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice.

  2019cites this paper
• Successful Inflammation Imaging of Non-Human Primate Hearts Using an Antibody Specific for Tenascin-C.

  2019cites this paper
• Medically Treated Ventricular Septal Perforation Caused by Takotsubo Cardiomyopathy.

  2019cites this paper
• Nanomedicine for Gene Delivery for the Treatment of Cardiovascular Diseases

  2019cites this paper
• New Trends in Vascular Inflammation Research: From Biology to Therapy

  2019cites this paper
• Enhanced monocyte recruitment and delayed alternative macrophage polarization accompanies impaired repair following myocardial infarction in C57BL/6 compared to BALB/c mice

  2019cites this paper
• Anti-HB-EGF Antibody-Mediated Delivery of siRNA to Atherosclerotic Lesions in Mice.

  2018cites this paper
• A Multicenter, Randomized, Placebo-Controlled Phase I Investigator-Initiated Trial for Intravenous Administration of Pitavastatin-Loaded PLGA Nanoparticles (NK-104-NP) in Healthy Japanese Male Subjects

  2018cites this paper
• Heart tissue repair and cardioprotection using drug delivery systems.

  2018cites this paper
• Nanoparticle-Mediated Targeting of Pitavastatin to Small Pulmonary Arteries and Leukocytes by Intravenous Administration Attenuates the Progression of Monocrotaline-Induced Established Pulmonary Arterial Hypertension in Rats.

  2018cites this paper
• Nanoparticles for postinfarct ventricular remodeling.

  2018cites this paper
• Apoptosis of bone marrow mesenchymal stromal/stem cells via the MAPK and endoplasmic reticulum stress signaling pathways.

  2018cites this paper
• Safety, Tolerability, and Pharmacokinetics of NK-104-NP.

  2018cites this paper
• Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models

  2018cites this paper
• Targeting necroptotic cell death pathway by high-intensity interval training (HIIT) decreases development of post-ischemic adverse remodelling after myocardial ischemia / reperfusion injury

  2018cites this paper
• Effects of Short-term High Dose Atorvastatin on Left Ventricular Remodeling in Patients with First Time Attack of Anterior Acute Myocardial Infarction.

  2018cites this paper
• Amlodipine Inhibits Vascular Cell Senescence and Protects Against Atherogenesis Through the Mechanism Independent of Calcium Channel Blockade.

  2018cites this paper
• Anti-inflammatory Nanomedicine for Cardiovascular Disease

  2017cites this paper
• Can Statins Modify the Wound Healing Process After Myocardial Infarction?

  2017cites this paper